FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024054494> ?p ?o ?g. }

• W2024054494 endingPage "156" @default.
• W2024054494 startingPage "144" @default.
• W2024054494 abstract "Parenteral iron nephrotoxicity: Potential mechanisms and consequences.BackgroundParenteral iron administration is a mainstay of anemia management in renal disease patients. However, concerns of potential iron toxicity persist. Thus, this study was conducted to more fully gauge iron toxicologic profiles and potential determinants thereof.MethodsIsolated mouse proximal tubule segments (PTS) or cultured proximal tubular [human kidney (HK-2)] cells were exposed to four representative iron preparations [iron sucrose (FeS), iron dextran (FeD), iron gluconate (FeG), or iron oligosaccharide (FeOS)] over a broad dosage range (0, 30 to 1000 μg iron/mL). Cell injury was assessed by lactate deyhdrogenase (LDH) release, adenosine triphosphate (ATP) reductions, cell cytochrome c efflux, and/or electron microscopy. In vivo toxicity (after 2 mg intravenous iron injections) was assessed by plasma/renal/cardiac lipid peroxidation [malondialdehyde (MDA)], renal ferritin (protein)/heme oxygenase-1 (HO-1) (mRNA) expression, electron microscopy, or postiron injection PTS susceptibility to attack.ResultsIn each test, iron evoked in vitro toxicity, but up to 30× differences in severity (e.g., ATP declines) were observed (FeS > FeG > FeD = FeOS). The in vitro differences paralleled degrees of cell (HK-2) iron uptake. In vivo correlates of iron toxicity included variable increases in renal MDA, ferritin, and HO-1 mRNA levels. Again, these changes appeared to parallel in vivo (glomerular) iron uptake (seen with FeS and FeG, but not with FeD or FeOS). Iron also effected in vivo alterations in proximal tubule cell homeostasis, as reflected by the “downstream” emergence of tubule resistance to in vitro oxidant attack.ConclusionParenteral iron formulations have potent, but highly variable, cytotoxic potentials which appear to parallel degrees of cell iron uptake (FeS > FeG > FeD or FeOS). That in vitro injury can be expressed at clinically relevant iron concentrations, and that in vivo glomerular iron deposition/injury may result, suggest caution is warranted if these agents are to be administered to patients with active renal disease. Parenteral iron nephrotoxicity: Potential mechanisms and consequences. Parenteral iron administration is a mainstay of anemia management in renal disease patients. However, concerns of potential iron toxicity persist. Thus, this study was conducted to more fully gauge iron toxicologic profiles and potential determinants thereof. Isolated mouse proximal tubule segments (PTS) or cultured proximal tubular [human kidney (HK-2)] cells were exposed to four representative iron preparations [iron sucrose (FeS), iron dextran (FeD), iron gluconate (FeG), or iron oligosaccharide (FeOS)] over a broad dosage range (0, 30 to 1000 μg iron/mL). Cell injury was assessed by lactate deyhdrogenase (LDH) release, adenosine triphosphate (ATP) reductions, cell cytochrome c efflux, and/or electron microscopy. In vivo toxicity (after 2 mg intravenous iron injections) was assessed by plasma/renal/cardiac lipid peroxidation [malondialdehyde (MDA)], renal ferritin (protein)/heme oxygenase-1 (HO-1) (mRNA) expression, electron microscopy, or postiron injection PTS susceptibility to attack. In each test, iron evoked in vitro toxicity, but up to 30× differences in severity (e.g., ATP declines) were observed (FeS > FeG > FeD = FeOS). The in vitro differences paralleled degrees of cell (HK-2) iron uptake. In vivo correlates of iron toxicity included variable increases in renal MDA, ferritin, and HO-1 mRNA levels. Again, these changes appeared to parallel in vivo (glomerular) iron uptake (seen with FeS and FeG, but not with FeD or FeOS). Iron also effected in vivo alterations in proximal tubule cell homeostasis, as reflected by the “downstream” emergence of tubule resistance to in vitro oxidant attack. Parenteral iron formulations have potent, but highly variable, cytotoxic potentials which appear to parallel degrees of cell iron uptake (FeS > FeG > FeD or FeOS). That in vitro injury can be expressed at clinically relevant iron concentrations, and that in vivo glomerular iron deposition/injury may result, suggest caution is warranted if these agents are to be administered to patients with active renal disease." @default.
• W2024054494 created "2016-06-24" @default.
• W2024054494 creator A5022845360 @default.
• W2024054494 creator A5059000580 @default.
• W2024054494 creator A5072621343 @default.
• W2024054494 date "2004-07-01" @default.
• W2024054494 modified "2023-10-01" @default.
• W2024054494 title "Parenteral iron nephrotoxicity: Potential mechanisms and consequences1" @default.
• W2024054494 cites W107186299 @default.
• W2024054494 cites W1967852740 @default.
• W2024054494 cites W1971995316 @default.
• W2024054494 cites W1972033007 @default.
• W2024054494 cites W1974702882 @default.
• W2024054494 cites W1975380578 @default.
• W2024054494 cites W1984656331 @default.
• W2024054494 cites W1986809119 @default.
• W2024054494 cites W1987137716 @default.
• W2024054494 cites W1988353980 @default.
• W2024054494 cites W1988838635 @default.
• W2024054494 cites W1990805586 @default.
• W2024054494 cites W1995253469 @default.
• W2024054494 cites W1995282389 @default.
• W2024054494 cites W1996372969 @default.
• W2024054494 cites W2003246990 @default.
• W2024054494 cites W2012578278 @default.
• W2024054494 cites W2028317647 @default.
• W2024054494 cites W2034019394 @default.
• W2024054494 cites W2041438931 @default.
• W2024054494 cites W2056311227 @default.
• W2024054494 cites W2058411952 @default.
• W2024054494 cites W2079019854 @default.
• W2024054494 cites W2091148694 @default.
• W2024054494 cites W2092619576 @default.
• W2024054494 cites W2093525170 @default.
• W2024054494 cites W2096487103 @default.
• W2024054494 cites W2104422885 @default.
• W2024054494 cites W2111498248 @default.
• W2024054494 cites W2111648863 @default.
• W2024054494 cites W2115485369 @default.
• W2024054494 cites W2123173784 @default.
• W2024054494 cites W2132857214 @default.
• W2024054494 cites W2138999309 @default.
• W2024054494 cites W2145269673 @default.
• W2024054494 cites W2151394521 @default.
• W2024054494 cites W2152102707 @default.
• W2024054494 cites W2169272593 @default.
• W2024054494 cites W2417774546 @default.
• W2024054494 cites W4210795904 @default.
• W2024054494 doi "https://doi.org/10.1111/j.1523-1755.2004.00716.x" @default.
• W2024054494 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15200421" @default.
• W2024054494 hasPublicationYear "2004" @default.
• W2024054494 type Work @default.
• W2024054494 sameAs 2024054494 @default.
• W2024054494 citedByCount "124" @default.
• W2024054494 countsByYear W20240544942012 @default.
• W2024054494 countsByYear W20240544942013 @default.
• W2024054494 countsByYear W20240544942014 @default.
• W2024054494 countsByYear W20240544942015 @default.
• W2024054494 countsByYear W20240544942016 @default.
• W2024054494 countsByYear W20240544942017 @default.
• W2024054494 countsByYear W20240544942018 @default.
• W2024054494 countsByYear W20240544942019 @default.
• W2024054494 countsByYear W20240544942020 @default.
• W2024054494 countsByYear W20240544942021 @default.
• W2024054494 countsByYear W20240544942022 @default.
• W2024054494 countsByYear W20240544942023 @default.
• W2024054494 crossrefType "journal-article" @default.
• W2024054494 hasAuthorship W2024054494A5022845360 @default.
• W2024054494 hasAuthorship W2024054494A5059000580 @default.
• W2024054494 hasAuthorship W2024054494A5072621343 @default.
• W2024054494 hasBestOaLocation W20240544941 @default.
• W2024054494 hasConcept C126189478 @default.
• W2024054494 hasConcept C126322002 @default.
• W2024054494 hasConcept C134018914 @default.
• W2024054494 hasConcept C150903083 @default.
• W2024054494 hasConcept C185592680 @default.
• W2024054494 hasConcept C207001950 @default.
• W2024054494 hasConcept C2776151105 @default.
• W2024054494 hasConcept C2776974161 @default.
• W2024054494 hasConcept C2777417653 @default.
• W2024054494 hasConcept C2778248108 @default.
• W2024054494 hasConcept C2778319317 @default.
• W2024054494 hasConcept C2780091579 @default.
• W2024054494 hasConcept C2780829032 @default.
• W2024054494 hasConcept C29730261 @default.
• W2024054494 hasConcept C3020614022 @default.
• W2024054494 hasConcept C55493867 @default.
• W2024054494 hasConcept C71924100 @default.
• W2024054494 hasConcept C86803240 @default.
• W2024054494 hasConcept C98274493 @default.
• W2024054494 hasConceptScore W2024054494C126189478 @default.
• W2024054494 hasConceptScore W2024054494C126322002 @default.
• W2024054494 hasConceptScore W2024054494C134018914 @default.
• W2024054494 hasConceptScore W2024054494C150903083 @default.
• W2024054494 hasConceptScore W2024054494C185592680 @default.
• W2024054494 hasConceptScore W2024054494C207001950 @default.
• W2024054494 hasConceptScore W2024054494C2776151105 @default.
• W2024054494 hasConceptScore W2024054494C2776974161 @default.

• next